Michael Polyviou | Managing Member, EVC Group |
William Annett | President & CEO |
Mitch Levine | CFO |
Lyndal Hesterberg | SVP, Research & Development |
Bruce Jackson | Lake Street Capital Markets |
Raymond Myers | Benchmark Company |
Paul Knight | Janney Montgomery Scott |
Keay Nakae | Chardan Capital Markets |
Good day and welcome to the OncoCyte Conference Call to Discuss First Quarter 2018 Financial Results. Today’s conference is being recorded. At this time, I’d like to turn the conference over to Mr. Michael Polyviou. Please go ahead.